Along with the Lowry news, Jets head coach Scott Arniel told the media Monday that forward Morgan Barron will be out week-to-week with an undisclosed injury. He also gave updates on Gustav Nyquist, ...

Forbes contributors publish independent expert analyses and insights. Rachel Wells is a writer who covers leadership, AI, and upskilling.

The Patriot Service Dogs, a nonprofit organization, recently presented an informative program at the Dunnellon Public Library. Julie Sanderson, the founder of this organization, brought one of their ...

Explore investment opportunities and navigate interest rates and inflation in 2024. Learn financial strategies for economic growth and wealth building. ‘Elaborate’ heist through hole in Florida mall’s ...

Usama has a passion for video games and a talent for capturing their magic in writing. He brings games to life with his words, and he's been fascinated by games for as long as he's had a joystick in ...

Leaders don’t need more slides—they need more sensemaking. The future of presentations is clarity, story, and presence, not polish. Do you recall sitting through a meeting where the slides just wouldn ...

The tight end position has long been one of the most unpredictable lineup slots in fantasy football. Outside of the few elite names, week-to-week production can be inconsistent, leaving managers ...

Here we will look at and discuss some bold predictions for the game between the Bills and the Panthers in Week 8 of the 2025 NFL season. The Bills (4-2) come in looking to shake off recent offensive ...

I told you last week that every time we say the tight end position is deep, the position lets us down. Then George Kittle scored zero, Michael Mayer scored two, Sam LaPorta scored 4.5, Dallas Goedert ...

When third-year outside linebacker Tavius Robinson went down with what was later revealed as a broken foot in Week 6, the Baltimore Ravens lost more than just their active sack leader and most ...

Both the Coca-Cola and Intuitive Surgical appear attractively valued, historically speaking. Roughly two-thirds of Wall Street pros rate the medical device maker a buy. Nearly 90% of analysts rate ...